Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Differential effects of interferon-β1b on cytokine patterns of CD4+ and CD8+ T cells derived from RRMS and PPMS patients.
The complex role of estrogens in inflammation.
Epitope spreading as an early pathogenic event in pediatric multiple sclerosis.
Defining the clinical course of multiple sclerosis: The 2013 revisions.
INF-β1b therapy modulates L-arginine and nitric oxide metabolism in patients with relapse remittent multiple sclerosis.
Development of oral immunomodulatory agents in the management of multiple sclerosis.
A timing-of-birth effect on multiple sclerosis clinical phenotype.
Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis.
A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis.
Suppression of CD4+ T cell activation by a novel inhibitor of Src family kinases.
Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells.
Estriol preserves synaptic transmission in the hippocampus during autoimmune demyelinating disease.
Structure of the LINGO-1-anti-LINGO-1 Li81 antibody complex provides insights into the biology of LINGO-1 and the mechanism of action of the antibody therapy.
Phase III study: Ocrelizumab significantly reduces disease activity in PPMS patients
Risk alleles for multiple sclerosis identified by a genomewide study.
IFN-β Treatment Requires B Cells for Efficacy in Neuroautoimmunity.
L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients.
Drug reprofiling using zebrafish identifies novel compounds with potential pro-myelination effects.
Japanese macaque encephalomyelitis: a spontaneous multiple sclerosis-like disease in a nonhuman primate.
Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients.
Biogen Idec and Genentech announce restructuring of anti-CD20 collaboration agreement
Teriflunomide for multiple sclerosis.
Equivalent Gene Expression Profiles between Glatopa™ and Copaxone®.
Fumaric Acid Esters Do Not Reduce Inflammatory NF-κB/p65 Nuclear Translocation, ICAM-1 Expression and T-Cell Adhesiveness of Human Brain Microvascular Endothelial Cells.
Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis.

Pages